AQR Arbitrage LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 18 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$5,486,000
-8.4%
5,200,0000.0%0.12%
-20.5%
Q1 2022$5,988,000
-30.6%
5,200,000
-32.5%
0.16%
-29.4%
Q4 2021$8,629,000
-5.4%
7,700,0000.0%0.22%
-15.3%
Q3 2021$9,119,000
-0.1%
7,700,0000.0%0.26%
+1.6%
Q2 2021$9,132,000
+7.0%
7,700,0000.0%0.26%
-16.3%
Q1 2021$8,532,000
-1.1%
7,700,0000.0%0.31%
+1.3%
Q4 2020$8,628,000
+12.0%
7,700,0000.0%0.30%
+8.2%
Q3 2020$7,704,0007,700,0000.28%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Opti Capital Management, LP 5,300,000$6,265,0000.59%
SHENKMAN CAPITAL MANAGEMENT INC 4,457,000$5,272,0000.40%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,416,000$12,314,0000.28%
AQR Arbitrage LLC 7,700,000$9,119,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 21,227,000$25,018,0000.22%
LINDEN ADVISORS LP 26,849,000$31,752,0000.19%
HBK INVESTMENTS L P 10,000,000$11,822,0000.05%
Calamos Advisors LLC 7,500,000$8,910,0000.04%
Jefferies Group LLC 3,245,000$3,856,6770.03%
CAPSTONE INVESTMENT ADVISORS, LLC 9,700,000$11,487,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders